Skip to content

Postoperative analgesic efficacy of 0.25% Ropivacaine with Dexmedetomidine versus Dexamethasone as adjuvants in Bilateral superficial cervical plexus block for Thyroidectomy surgery under general anesthesia in a tertiary care center in Wayanad.

Postoperative analgesic efficacy of 0.25% Ropivacaine with Dexmedetomidine versus Dexamethasone as adjuvants in Bilateral superficial cervical plexus block for Thyroidectomy surgery under general anesthesia-Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096303
Enrollment
86
Registered
2025-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bilateral superficial cervical plexus block: To compare analgesicefficacy of 0.25 % Ropivacaine based Bilateral superficial cervical plexus block with dexmedetomidine versus dexamethaso

Sponsors

Dr Moopen’s Medical College, Wayanad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elective thyroidectomy surgery Belonging to ASA Class 1&2

Exclusion criteria

Exclusion criteria: Patients with altered cervical plexus anatomy Coagulation disorders Systemic infection and infection at injection site History of allergy to local anesthetic agents

Design outcomes

Primary

MeasureTime frame
To Understand which among the two adjuvants offers superior postoperative analgesia,fewer complications and better patient satisfactionTimepoint: Time points used for Postoperative Analgesia comparison is zeroth hour( immediately after coming out of general anesthesia),2 hours ,6hours,12 hours and 24 hours

Secondary

MeasureTime frame
To compare the total analgesic consumption within the twogroupsTimepoint: Within the first 24 hours after surgery;To assess intraoperative hemodynamic stability in both groupsTimepoint: Throughout the surgey;To compare the incidence of side effects/complications related to the block & adjuvantsTimepoint: Within the first 24 hours after the surgery

Countries

India

Contacts

Public ContactDr Aruna Tegginamath

Dr Moopen’s Medical College, Wayanad

shraddhakrupa27@gmail.com9243507325

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026